Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 2:08 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 24 matching trials from the live ClinicalTrials.gov search.

Filters: Sponsor: Dey Clear all

Conditions: COPD, Chronic Obstructive Pulmonary Disease
Interventions: Formoterol Fumarate; Drug
Lead sponsor: Dey; Industry
Eligibility: 5 Years to 70 Years
Enrollment: 49 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Ends 2005
U.S. locations: 7
States / cities: Phoenix, Arizona • Wheat Ridge, Colorado • Hines, Illinois + 4 more

Conditions: ACUTE SINUSITIS
Interventions: Cyclamen Europaeum; Drug
Lead sponsor: Dey; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 25
States / cities: Birmingham, Alabama • Oxford, Alabama • Jonesboro, Arkansas + 19 more

Conditions: COPD
Interventions: Formoterol Fumarate; Drug
Lead sponsor: Dey; Industry
Eligibility: 40 Years and older
Enrollment: 345 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 44
States / cities: Jasper, Alabama • Phoenix, Arizona • Tuscon, Arizona + 40 more

Conditions: Chronic Obstructive Pulmonary Disease, COPD, Chronic Bronchitis, Emphysema
Interventions: formoterol fumarate; Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 40 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Chronic Obstructive Pulmonary Disease
Interventions: Fluticasone Propionate/Formoterol Fumarate, Formoterol Fumarate, Placebo; Drug
Lead sponsor: Dey; Industry
Eligibility: 40 Days and older
Enrollment: 468 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 23
States / cities: Phoenix, Arizona • Fullerton, California • San Diego, California + 20 more

Conditions: COPD
Interventions: Formoterol Fumarate, Tiotropium Bromide; Drug
Lead sponsor: Dey; Industry
Eligibility: 40 Years and older
Enrollment: 128 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006
U.S. locations: 17
States / cities: Phoenix, Arizona • Los Angeles, California • Sepulveda, California + 14 more

Conditions: Prematurity, Respiratory Distress Syndrome, Patent Ductus Arteriosus
Interventions: Survanta (beractant), Curosurf (poractant); Drug
Lead sponsor: Alan Fujii; Other
Eligibility: Up to 8 Hours
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: COPD
Interventions: Formoterol Fumarate; Drug
Lead sponsor: Dey; Industry
Eligibility: 50 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Ends 2005
U.S. locations: 7
States / cities: Los Angeles, California • Upland, California • Denver, Colorado + 4 more

Conditions: Asthma
Interventions: Fluticasone Propionate; Drug
Lead sponsor: Dey; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 629 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Greenville, South Carolina

Conditions: Asthma
Interventions: Formoterol Fumarate; Drug
Lead sponsor: Dey; Industry
Eligibility: 5 Years to 70 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Ends 2005
U.S. locations: 3
States / cities: Long Beach, California • Denver, Colorado • Medford, Oregon

Conditions: Asthma
Interventions: Formoterol Fumarate; Drug
Lead sponsor: Dey; Industry
Eligibility: 5 Years to 12 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Ends 2005
U.S. locations: 12
States / cities: Little Rock, Arkansas • Long Beach, California • Mission Viejo, California + 9 more

Conditions: Chronic Obstructive Pulmonary Disease
Interventions: Formoterol Fumurate inhalation solution 20 mcg, Ipratropium bromide 18 mcg and albuterol sulfate 103 mcg; Drug
Lead sponsor: Dey; Industry
Eligibility: 40 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007
U.S. locations: 15
States / cities: San Diego, California • Denver, Colorado • Wheat Ridge, Colorado + 12 more

Conditions: COPD
Interventions: Formoterol Fumarate; Drug
Lead sponsor: Dey; Industry
Eligibility: 40 Years and older
Enrollment: 690 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Ends 2006
U.S. locations: 68
States / cities: Bessemer, Alabama • Birmingham, Alabama • Phoenix, Arizona + 55 more

Conditions: Asthma
Interventions: Formoterol Fumarate; Drug
Lead sponsor: Dey; Industry
Eligibility: 12 Years to 70 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2005
U.S. locations: 2
States / cities: Denver, Colorado • Medford, Oregon

Conditions: Chronic Obstructive Pulmonary Disease
Interventions: fluticasone propionate/formoterol fumarate, fluticasone propionate, formoterol fumarate; Drug
Lead sponsor: Dey; Industry
Eligibility: 40 Years and older
Enrollment: 97 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 12
States / cities: San Diego, California • Panama City, Florida • Madisonville, Kentucky + 9 more

Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Formoterol Fumarate, Foradil Aerolizer; Drug
Lead sponsor: Dey; Industry
Eligibility: 40 Years and older
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2010
U.S. locations: 4
States / cities: Clearwater, Florida • DeLand, Florida • Greenville, South Carolina + 1 more

Conditions: Chronic Obstructive Pulmonary Disease
Interventions: formoterol fumarate inhalation solution; Drug
Lead sponsor: Dey; Industry
Eligibility: 40 Years and older
Enrollment: 128 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 19
States / cities: Mobile, Alabama • Phoenix, Arizona • DeLand, Florida + 16 more

Conditions: Asthma
Interventions: Formoterol Fumarate; Drug
Lead sponsor: Dey; Industry
Eligibility: 5 Years to 11 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2005
U.S. locations: 2
States / cities: Long Beach, California • Medford, Oregon

Conditions: Chronic Obstructive Pulmonary Disease
Interventions: Fluticasone Propionate/Formoterol Fumarate, Fluticasone Propionate, Formoterol Fumarate, Fluticasone Propionate/Salmeterol Xinafoate, Placebo; Drug
Lead sponsor: Dey; Industry
Eligibility: 40 Years and older
Enrollment: 457 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 49
States / cities: Birmingham, Alabama • Jasper, Alabama • Phoenix, Arizona + 44 more

Conditions: Asthma
Interventions: Fluticasone Propionate (FP); Drug
Lead sponsor: Dey; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 498 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Rock Hill, South Carolina

Conditions: Respiratory Distress Syndrome, Newborn
Interventions: Extubation to Nasal IPPV; Other
Lead sponsor: University of Southern California; Other
Eligibility: 10 Minutes to 120 Minutes
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 4
States / cities: Los Angeles, California • San Diego, California • Augusta, Georgia + 1 more

Conditions: COPD
Interventions: Perforomist-Placebo, Perforomist, nebulization, COPD; Drug
Lead sponsor: Dey; Industry
Eligibility: 40 Years and older
Enrollment: 1,071 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Greenville, South Carolina

Conditions: COPD
Interventions: Formoterol Fumarate; Drug
Lead sponsor: Dey; Industry
Eligibility: 40 Years and older
Enrollment: 345 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 52
States / cities: Jasper, Alabama • Phoenix, Arizona • Buena Park, California + 47 more

Conditions: Healthy
Interventions: Fluticasone Propionate, Formoterol Fumarate; Drug
Lead sponsor: Dey; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Ends 2005
U.S. locations: 1
States / cities: Lenexa, Kansas

Search by objective public record fields.

Study in Patients With COPD

Pilot Study to Determine Efficacy of Cyclamen Europaeum Extract Nasal Spray in Patients With Acute Sinusitis

A Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate in the Treatment of Patients With COPD

Perforomist Versus Foradil Evaluated by Inspiratory Capacity and High Resolution Computed Tomography (HRCT)

A Trial to Assess the Pharmacodynamic Response in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

A Phase IIIB Study to Compare the Efficacy and Safety of Concomitant Treatment in Patients With COPD

Curosurf and Survanta Treatment(CAST)of RDS in Very Premature Infants

Study in Patients With COPD

12-Week Study in Adult Subjects With Asthma

Study in Patients With Asthma

Study in Patients With Asthma

A Crossover Study in the Treatment of Patients With COPD

Study in Patients With COPD

Study in Patients With Asthma

A Study Evaluating Systemic Exposure and Pharmacodynamics in Patients With Chronic Obstructive Pulmonary Disease

A Study Characterizing Pharmacodynamic Profiles in Subjects With Chronic Obstructive Pulmonary Disease

Study in Subjects Greater Than 40 Years of Age With COPD

Study in Patients With Asthma

A Dose-Finding Study Evaluating Safety and Efficacy in Patients With Chronic Obstructive Pulmonary Disease

A 12-Week Study in Adult Subjects With Asthma

Synchronized Intermittent Mandatory Ventilation (SIMV) Versus Nasal Intermittent Positive Pressure Ventilation (NIPPV) In Preterm Infants With Respiratory Distress

Study to Evaluate the Safety of Long-Term Use of Perforomist® (Formoterol Fumarate)

A Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate 20 Mcg/0.5 mL in the Treatment of Patients With COPD

A Study in Healthy Volunteers to Evaluate Serum and Urine Levels of the Investigational Product Versus Comparator.